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steoclast (OC) precursors migrate to putative sites
of bone resorption to form functionally active,
multinucleated cells. The preOC FLG 29.1 cells,
known to be capable of irreversibly differentiating into
multinucleated OC-like cells, displayed several features of
primary OCs, including expression of speciﬁc integrins and
the hyaluronan (HA) receptor CD44. OC-like FLG 29.1 cells
adhered to and extensively migrated through membranes
coated with ﬁbronectin, vitronectin, and laminins, but,
although strongly binding to HA, totally failed to move on this
substrate. Moreover, soluble HA strongly inhibited OC-like
FLG 29.1 cell migration on the permissive matrix substrates,
and this behavior was dependent on its engagement with
O
 
CD44, as it was fully restored by function-blocking anti-CD44
antibodies. HA did not modulate the cell–substrate binding
afﬁnity/avidity nor the expression levels of the corresponding
integrins. MMP-9 was the major secreted metalloproteinase
used by OC-like FLG 29.1 cells for migration, because this
process was strongly inhibited by both TIMP-1 and GM6001,
as well as by MMP-9–speciﬁc antisense oligonucleotides.
After HA binding to CD44, a strong down-regulation of
MMP-9 mRNA and protein was detected. These ﬁndings high-
light a novel role of the HA–CD44 interaction in the context
of OC-like cell motility, suggesting that it may act as a stop
signal for bone-resorbing cells.
 
Introduction
 
Mononuclear osteoclast (OC)* precursors egress from the
bloodstream and migrate to the bone surface where they
form functionally active multinucleated bone-resorbing cells
under the influence of several cytokines, including M-CSF
and RANKL (Roodman, 1996; Lacey et al., 1998; Arai et
al., 1999; Teitelbaum, 2000). Once attached to bone, OCs
initiate the resorption process through the activation of a
complex cascade of morphological and biochemical changes
involving expression of adhesion molecules and secretion of
proteolytic enzymes. In addition to cathepsin K (Inaoka et
al., 1995), several lines of evidence indicate the critical role
of matrix metalloproteinases (MMPs), and in particular,
MMP-9 for OC migration and function. MMP-9 has been
associated exclusively with OCs among the cells involved in
bone formation and resorption in both human (Okada et al.,
1995) and rabbit (Tezuka et al., 1994) tissues. In addition, it
has proven to be indispensable for the migration of OCs
through collagen both in periosteum and developing marrow
cavity of primitive long bones (Blavier and Delaisse, 1995;
Sato et al., 1998). Moreover, bone resorption was reduced in
mice carrying a mutation in the type-I collagen site targeted
by neutral collagenases (Zhao et al., 1999), and the natural
tissue inhibitor of MMP activity, tissue inhibitor of metallo-
proteinase 1 (TIMP-1), expressed by OCs (Hill et al.,
1994), inhibits bone resorption in organ cultures (Bord et
al., 1999). Finally, the localization of membrane-type 1
MMP in invadopodia and lamellipodia of OCs suggested a
role in OC invasion/migration phenomena for this membrane-
bound protease (Sato et al., 1997).
Coordinated regulation and appropriate site-specific migra-
tion and bone adhesion of OCs toward different ECM
substrates (such as collagens, fibronectin [FN], vitronectin
[VN], and laminins [LNs]) in the spaces surrounding and
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within the bone matrix are mediated by various receptor sys-
tems, including integrins. Among the integrins involved in
OC biology and motility, a fundamental role has been rec-
ognized for 
 
 
 
v
 
 
 
3, although bone resorption may also be
partially inhibited by functional blocking of the 
 
 
 
2
 
 
 
1 inte-
grin (Duong et al., 2000). Another important class of OC
adhesion receptors is represented by CD44 (Nakamura and
Ozawa, 1996; Kania et al., 1997). CD44 is a cell surface,
single-pass transmembrane part time proteoglycan expressed
in a variety of cells of hemopoietic and nonhemopoietic ori-
gin (Aruffo, 1996; Naor et al., 1997; Borland et al., 1998;
Lesley and Hyman, 1998; Rochman et al., 2000). The pur-
ported functions of CD44 are diverse, but by far the greatest
interest in CD44 has been in relation to its function as a re-
ceptor for hyaluronan (HA). HA is a member of the gly-
cosaminoglycan long nonbranching aminosugar polysaccha-
rides that resides and exerts its function primarily within the
extracellular space (Lee and Spicer, 2000), including those
immediately surrounding bone matrices (Noonan et al.,
1996). The roles of HA range from a purely structural func-
 
tion to regulation of cell motility and adhesion, as well as re-
ceptor-mediated changes in gene expression (Lee and Spicer,
2000). Experimental evidence indicates that binding of HA
to CD44 can also be regulated through glycosylation and a
variety of other posttranslational modifications (Bartolazzi et
al., 1996). Furthermore, CD44 engagement can activate
several downstream pathways through specific intermediates
(Ilangumaran et al., 1999; Mangeat et al., 1999). The cellu-
lar and molecular mechanisms by which integrins contribute
to cell migration processes have been extensively established
(Holly et al., 2000); however, although the dependence of
cell motility on CD44 has been demonstrated in several in
vitro models (Thomas et al., 1993; Okada et al., 1996; Tro-
chon et al., 1996; Ladeda et al., 1998; Okamoto et al., 1999;
Kajita et al., 2001), the regulation of CD44-mediated motil-
ity has been less thoroughly investigated.
The human continuous cell line (FLG 29.1) of bone
marrow–derived preosteoclast (preOC) cells provides a
valuable model to investigate specific aspects of OC biol-
ogy (Gattei et al., 1992). FLG 29.1 preOC cells can be ir-
Figure 1. Expression of adhesion receptors by preOC and OC-like FLG 29.1 cells. (A) Cell surface expression of selected integrin receptors 
by pre-OC (dotted line) and OC-like (bold line) FLG.29.1 cells as assessed by flow cytometry. Binding of an unrelated isotype-matched 
control is reported as a thin line. Histograms indicate log fluorescence intensity (x axis) versus relative cell number (y axis). (B, left) Kinetics of 
cell surface expression of the CD44 receptor; the time in hours after induction is shown. MsIg indicates the binding of an isotype-matched 
unrelated antibody. (B, right) Immunoblotting of CD44. Lysates from preOC (lane 1) and OC-like (lane 2) cells were resolved on an 8% 
SDS-PAGE, transferred to nitrocellulose filters, and probed with anti-CD44 pAbs. (C) RT-PCR analysis of the expression of CD44 alternatively 
spliced exons in OC-like FLG 29.1 cells. Amplified products were run on a 1.5% agarose gel (top), blotted onto nylon membranes, and 
hybridized with a probe chosen to recognize sequences within exon 5 (bottom). Negative control ( ) was done by omitting cDNA. Asterisks 
indicate DNA markers. 
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reversibly induced to differentiate into adherent, nondi-
viding multinucleated OC-like cells displaying several
features of primary OCs, including a specific immunophe-
notypic profile, tartrate-resistant acid phosphatase, and
calcitonin and estrogens receptors, as well as the capability
to degrade bone (Fiorelli et al., 1994, 1995; Gattei et al.,
1996). Using these cells, we demonstrate a new role for the
CD44-HA interaction in the regulation of cell migration.
Engagement of CD44 by its specific ligand HA signifi-
cantly impairs the migration of OC-like FLG 29.1 cells to-
ward several ECM substrates by down-regulating the pro-
duction of the locomotion-associated protease MMP-9.
According to this in vitro model, the CD44-HA interac-
tion may represent a novel motility stop signal that could
also play a role in vivo to counterbalance the invasive ac-
tivity exhibited by OC cells to gain access to and for an-
chorage at the bone surface.
 
Results
 
Integrin expression by OC-like FLG 29.1 cells
 
In agreement with data obtained on primary OCs (Kania et
al., 1997), the acquisition by FLG 29.1 cells of the OC-like
phenotype was associated with an up-regulation of the con-
stitutively expressed 
 
 
 
1, 
 
 
 
v, and 
 
 
 
5 integrin chains, and a
de novo expression of 
 
 
 
v
 
 
 
3, 
 
 
 
3, and 
 
 
 
3 integrins (Fig. 1 A).
Moreover, independently of the differentiation status, FLG
29.1 cells transcribed mRNA for both 
 
 
 
8 and 
 
 
 
9 integrin
subunits (unpublished data), whereas they did not express
selectins, 
 
 
 
2 family integrins, 
 
 
 
5, 
 
 
 
7, 
 
 
 
1, 
 
 
 
2, 
 
 
 
4, and 
 
 
 
6
integrin subunits (unpublished data).
 
CD44 expression by OC-like FLG 29.1 cells
 
CD44, undetectable in preOC FLG 29.1 cells, was strikingly
induced in a time-dependent manner upon OC-like differen-
tiation (Fig. 1 B, left). Immunoblotting of cell lysates were in
full accord with flow cytometry data and indicated no expres-
sion of CD44 in preOC cells and expression of the standard
hemopoietic CD44 form in OC-like cells (Fig. 1 B, right).
Only upon long exposures, very faint higher 
 
M
 
r
 
 bands were
visible in OC-like cells, suggesting that variants including ad-
ditional exons could be expressed at very low levels. Consis-
tently, as analyzed by RT-PCR, only low amounts of
standard CD44 mRNAs were detected in preOC cells. Tran-
scripts of this isoform were increased in OC-like FLG 29.1
cells, along with those corresponding to CD44v6 and
CD44v8–10 alternatively spliced variants (Fig. 1 C).
 
Cell adhesion to ECM substrates
 
PreOC FLG 29.1 cells bound in a cation-dependent manner
to FN and to VN, but not to fibrinogen, type I collagen, and
LNs (Fig. 2 A). Upon induction of differentiation, FLG
29.1 cells displayed an increased ability to attach to FN and
VN, and acquired the capability to adhere to several LNs,
mainly LN-8, and LN-10 isoforms (Fig. 2 A). As expected,
adhesion of OC-like FLG 29.1 cells to FN, LN-8, and LN-
10, but not VN, was completely abrogated by an anti-
 
 
 
1 in-
tegrin subunit-blocking mAb (Fig. 2 B). Similarly, anti-
 
 
 
v
 
 
 
3 and anti-
 
 
 
3–specific mAbs significantly inhibited cell
attachment to VN and LN-10, respectively (Fig. 2 B). OC-
like FLG 29.1 cells also bound tenaciously and in a dose-
dependent manner to surface-immobilized high 
 
M
 
r
 
 HA,
reaching 50% cell binding at coating concentrations as low
as 15–20 
 
 
 
g/ml HA (Fig. 3 A). HA binding to OC-like cells
was entirely mediated by CD44 because staining with
FITC-HA was fully abrogated by an excess of the function-
blocking anti-CD44 mAb, BRIC235 (Fig. 3 B). Consis-
tently, the same and other function-blocking anti-CD44
mAbs completely abolished adhesion of OC-like cells to im-
mobilized HA, but not to FN substrates (Fig. 3, C and D).
 
HA engagement of CD44 inhibits migration of OC-like 
FLG 29.1 cells toward purified ECM molecules 
 
Although preOC FLG 29.1 cells were totally unable to mi-
grate toward all the various ECM substrates assayed (Fig. 4
A), differentiated OC-like FLG 29.1 cells migrated toward
FN-, VN-, LN-8–, and LN-10–coated membranes. A signif-
icant number of migrated cells were detected as early as 6 h,
indicating an enhanced locomotion activity on differentia-
tion (Fig. 4 A, top). In agreement with the adhesive behavior
and integrin expression pattern of OC-like FLG 29.1 cells,
movement toward VN- and LN-10–coated membranes was
Figure 2. Cell adhesion to ECM 
proteins. (A, top) Cell adhesion to FN, VN, 
fibrinogen (Fb), and type I collagen (Col I). 
Substrate proteins were coated at 10  g/ml 
and cell adhesion was performed in the 
presence of 1.0 mM Mg
2  and 1.0 mM 
Ca
2  or 10  M Mn
2  for VN. The values 
reported represent the average of three 
experiments. (A, bottom) Cell adhesion 
to different LN isoforms coated at 
10  g/ml. Cell adhesion was performed 
as in A. (B) Inhibition of OC-like FLG 
29.1 cell adhesion by integrin-specific 
antibodies. For the inhibition of cell 
adhesion, different antibodies were 
added at 5  g/ml just before plating the 
cells. The following antibodies were 
used: FB12 ( 1), P1F6 ( v 5), LM 609 
( v 3), P1B5 ( 3), and 4B4 ( 1). 
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mediated by the 
 
 
 
v
 
 
 
3 and 
 
 
 
3
 
 
 
1 integrins, respectively, as
indicated by inhibition of migration upon exposure to spe-
cific function-blocking mAbs (unpublished data). Similarly,
migration toward FN was presumably largely mediated by
the 
 
 
 
5
 
 
 
1 integrin, because this movement was significantly
hampered (
 
 
 
80%) by the addition of the anti-
 
 
 
1 4B4 mAb
(unpublished data). In contrast, despite the significant ex-
pression of CD44 (Fig. 1 B) and the strong adhesion to HA
(Fig. 3), OC-like FLG 29.1 cells completely failed to move
toward HA-coated membranes at 6 and even at 20 h (Fig. 4
A). The motility response to HA was unaffected by any pu-
tative chemotactic stimulus provided by conditioned media
from the C433 stromal cell line, known to contain several
OC-specific differentiation-inducing factors (Gattei et al.,
1996), or from NIH 3T3 fibroblasts (unpublished data).
To investigate the effects of HA on OC-like FLG 29.1 cell
migration in response to other ECM substrates, we hypothe-
sized that HA may actively participate in some regulatory as-
pects of OC-like cell motility. Thus, soluble HA was added
during a standard migration assay toward various ECM sub-
strates (Fig. 4 B). In the presence of intact HA, the number
of migrating cells on FN was found to be dose-dependently
reduced at both 6 and 20 h (Fig. 4 B). This phenomenon
was clearly dependent on binding of HA to CD44 because
the addition of the anti-CD44–blocking mAb (BRIC235)
fully restored the migratory behavior of OC-like cells toward
FN (Fig. 4 B). A similar inhibitory effect of soluble HA on
the migration of OC-like FLG 29.1 cells was also demon-
strated when VN and LN-10 were used as substrates (un-
published data).
 
CD44 engagement does not affect adhesion of OC-like 
FLG 29.1 cells to ECM
 
Although mediated by a specific CD44-HA interaction, the
inhibition of migration toward ECM substrates by soluble
HA could depend on a mere steric blockade of the interaction
between the ligand and its specific receptor. To address this is-
sue, we investigated the relative adhesive strength of the
cells to FN in the presence of HA. For this purpose, we per-
formed centrifugal assay for fluorescence-based cell adhesion
Figure 3. Cell adhesion to HA. (A) Dose–response of cell adhesion. HA was coated at different concentrations and the cell adhesion assay 
was performed with preOC (open circles) or OC-like (closed circles) FLG 29.1 cells in the presence of 1.0 mM Mg
2  and 1.0 mM Ca
2 . 
(B) The HA receptor on OC-like cells is CD44. Cells were probed with 0.8  g/ml FITC-HA in the absence or presence of a CD44 function–
blocking mAb (BRIC 235). (C) Inhibition of cell adhesion. For the quantitative evaluation of CD44-dependent inhibition of cell adhesion to 
HA coated at 0.5 mg/ml, the different function-blocking mAbs (5  g/ml) were added just before plating the cells. Adhesion onto FN in the 
presence of an anti-CD44 function-blocking mAb is shown for comparison. (D) Adhesion to HA. Phase-contrast micrograph of adherent 
preOC or OC-like cells to HA-coated at 0.5 mg/ml in the absence or presence of BRIC 235. Bar, 100  m. 
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(CAFCA) assays in the presence of 0.5 or 1.0 mg/ml of HA,
capitalizing on the fact that this assay can measure the
strength of adhesion by varying the detachment forces (Spes-
sotto et al., 2000, 2001). As shown in Fig. 5 A, soluble HA
did not affect the attachment of OC-like FLG 29.1 cells to
FN substrates, even when the maximal detachment force (400 
 
g
 
)
was applied. Similar results were obtained using VN and
LN-10 as adhesive substrates (unpublished data). This adhe-
sion was mediated by the interaction between the FN sub-
strate and its specific integrin receptor because the addition of
a function-blocking anti-
 
 
 
1 mAb fully inhibited the adhesion
of OC-like FLG 29.1 cells to FN, also in the presence of solu-
Figure 4. Cell migration toward ECM 
substrates. (A) Migration in response to 
various ECM substrates was evaluated at 
two time points (6 and 20 h). The filters 
were coated on the underside with 
20  g/ml of the various substrates. 
(B) Inhibition of cell migration toward FN 
by engagement of CD44 by soluble HA. 
Dose–response inhibition was evaluated 
at two time points in the presence of 100 
or 500  g/ml of soluble high molecular 
mass HA. The simultaneous presence of 
the BRIC235 mAb blocking the CD44-HA 
interaction reversed the HA-dependent 
inhibition. In both cases, the values 
shown represent the mean   SEM of 
three experiments.
Figure 5. Effect of HA on OC-like cell 
adhesion to FN. (A) Assessment of the 
relative avidity of cell adhesion onto FN 
in the presence of HA by varying the 
centrifugal force (45 g, 180 g, and 400 g) 
applied to dislodge bound cells. Cells 
were allowed to adhere to FN coated at 
5  g/ml. (B) Adhesion to FN in the 
presence of HA or the 4B4 function-
blocking anti- 1 mAb. (C) Assessment 
of the relative avidity of cell adhesion to 
FN of cells maintained for 24 h in the 
presence of soluble HA by varying the 
centrifugal force (45 g, 180 g, and 400 g) 
applied to dislodge bound cells. 
(D) Phase-contrast (p.c.) morphology 
and CD44/actin staining of adherent 
OC-like FLG 29.1 cells to FN-coated 
slides (20  g/ml) at 20  g/ml in the 
absence or presence of 1.0 mg/ml HA. 
Bars, 100  m. 
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ble HA (Fig. 5 B). Another possibility could be that the addi-
tion of soluble HA could affect, via an inside-out mechanism
mediated by the cytoplasmic domain of CD44, the affinity/
avidity of integrin receptors for their cognate ligands. Thus,
additional adhesion experiments were performed with OC-
like FLG 29.1 cells grown in the presence of soluble HA for
24 h and then assayed with CAFCA at different detachment
forces (45 
 
g
 
, 180 
 
g
 
, and 400 
 
g
 
) in the absence of HA. Again,
no significant difference was noted when compared with con-
trol cells grown in the absence of HA (Fig. 5 C). Consistently,
the presence of soluble HA affected neither the expression lev-
els of 
 
 
 
5
 
 
 
1 and 
 
 
 
v
 
 
 
1 integrins on OC-like FLG 29.1, as
evaluated by flow cytometry (unpublished data), nor the mor-
phology of cells attached to FN, nor the even cell membrane
distribution of CD44 molecules (Fig. 5 D).
 
MMP-9 is the major metalloproteinase involved in 
OC-like FLG 29.1 cell migration
 
MMPs represent indispensable factors for the regulation of
specific OC functions, including migration to the bone sur-
face (Blavier and Delaisse, 1995; Vu et al., 1998; Lee et al.,
1999; Engsig et al., 2000). Accordingly, consistent levels of
MMP-9 (
 
M
 
r
 
 
 
  92 kD) were detected in conditioned media
from fully differentiated OC-like FLG 29.1 cells (Fig. 6 A,
lane 3), MMP-9 levels being further up-regulated by expo-
sure to TNF-  (Fig. 6 A, lane 4), a strong inducer of MMP-9
expression (Zhang et al., 1998). On the contrary, although
no MMP-9 was seen in preOC cell supernatants (Fig. 6 A,
lane 1), a discrete MMP-9–related gelatinolytic activity was
revealed on exposure of preOC cells to TNF-  (Fig. 6 A,
lane 2). Other MMPs known to be expressed by OCs such
as MMP-2 (Mr   72 kD) and MMP-13 (Mr   54/42 kD)
were not expressed by FLG 29.1 cells both in zymograms
(Fig. 6 A) and RT-PCR (unpublished data). By comparing
MMP-9 levels in cell medium and cell lysates of OC-like
cells, MMP-9 released in the supernatant represented  90%
of the whole detectable amount of activity both in the pres-
ence and absence of TNF-  (Fig. 6 B, lanes 1 and 2). How-
ever, in cell lysates, detectable amounts of active MMP-9
were demonstrable (Fig. 6 B, lane 3), which significantly in-
creased on exposure to TNF-  (Fig. 6 D, lane 4).
To evaluate whether MMP-9 may be critical for the motil-
ity of OC-like FLG 29.1 cells, migration assays were per-
formed in the presence or absence of an excess of MMP inhib-
itors. As shown in Fig. 7 A, the addition of the natural
inhibitor of MMPs, TIMP-1, as well as of the synthetic inhib-
itor of MMP activity, GM6001 (Leppert et al., 1995), almost
fully abrogated cell migration toward FN-coated membranes.
To formally demonstrate that MMP-9 was involved in migra-
tion of OC-like FLG 29.1 cells, we tested whether the inhibi-
tion of MMP-9 expression by antisense treatment could affect
cell migration toward FN. On exposure to specific antisense
oligonucleotides, the expression of MMP-9 mRNA, as inves-
tigated by real-time quantitative PCR, was dose-dependently
reduced with a nearly full inhibition at 10  M (Fig. 7 B). Ac-
cordingly, a consistent inhibition of cell migration was at-
tained, reaching 75% reduction compared with control, when
10  M of antisense oligonucleotide was added (Fig. 7 C). Ex-
pression of surface CD44 in OC-like cells exposed to anti-
sense treatment, as evaluated by flow cytometry, was totally
unaffected (unpublished data), thus excluding the possibility
that the inhibitory effects on migration could result from a
mere down-regulation of CD44. These experiments concor-
dantly suggested that motility of OC-like FLG 29.1 cells was
under the influence of MMPs, likely MMP-9.
HA engagement of CD44 affects MMP-9 expression
OC-like FLG 29.1 cells grown for 24 h onto ECM substrates
such as FN or VN did not change the levels of MMP-9 de-
tected in their supernatants when compared with cells grown
on tissue culture plastic (Fig. 8 A, lanes 1, 7, and 9). On the
other hand, in the presence of soluble HA, a strong and dose-
dependent reduction of MMP-9 expression was observed
(Fig. 8 A, lanes 2–6), reaching 85% in the presence of 1.0
mg/ml HA. Such inhibitory effect was maintained or even
increased when cells were cultured on FN (Fig. 8 A, lane 8)
or VN (Fig. 8 A, lane 10) substrates ( 50% reduction at 0.1
mg/ml HA). Consistently, immunoblotting of TCA-precipi-
tated supernatants from OC-like cells grown in the presence
of 1.0 mg/ml HA demonstrated a 70% reduction of MMP-9,
as compared with control samples (Fig. 8 B). The HA-depen-
dent reduction of MMP-9 production in supernatants was
confirmed in cytoplasms of OC-like cells also when the ex-
pression of MMP-9 was increased upon TNF-  stimulation
(Fig. 8 C). In accordance with these findings, significantly
lower levels of MMP-9 transcripts were detected by real-time
PCR in OC-like FLG 29.1 cells grown onto different sub-
strates in the presence of soluble HA (Fig. 8 D). This down-
regulation was rescued by treatment with the function-block-
ing anti-CD44 mAb BRIC235 (Fig. 8 D, lanes 3 and 6).
Taken together, these data concordantly suggest that the
CD44-HA interaction was directly responsible for the inhibi-
tion of the MMP-9 synthesis. Conversely, engagement of
CD44 with HA did not result in any change in the expres-
sion levels of the standard hemopoietic CD44 form both in
OC-like cells (Fig. 8 E, lanes 2 and 3) and in OC-like cells
exposed to TNF-  (Fig. 8 E, lanes 5 and 6). Consistently, no
cleaved extracellular CD44 could be detected in the corre-
sponding cell supernatants (unpublished data).
Figure 6. Expression of MMP-9. (A) Pro–MMP-9 expression in the 
supernatant of preOC or OC-like cells (5   10
5/lane) in the absence 
or presence of TNF-  (10 ng/ml). Expression was evaluated with 
zymography. (B) Pro–MMP-9 and active MMP-9 in supernatants 
and cell lysates of OC-like cells in the absence or presence of TNF- . 
Only the relevant part of the gel is shown. HA–CD44 binding down-regulates cell movement | Spessotto et al. 1139
Discussion
The FLG 29.1 cell line had originally been proposed as a
valid in vitro model of OC-like differentiation (Gattei et al.,
1992). Since then, additional experimental evidence has
been accumulated to strengthen the close relationship be-
tween normal OC precursors and the OC-like FLG 29.1
cells, further validating the use of this cell system for investi-
gating OCs differentiation/maturation and their functional
activity (Gattei et al., 1992, 1996; Fiorelli et al., 1994,
1995). In the present study, by taking advantage of the FLG
29.1 cell system, we demonstrate a novel MMP-9–depen-
dent mechanism of inhibition of cell migration along spe-
cific ECM substrates, which is conferred by engagement of
HA to CD44, one of the major adhesion receptors expressed
by OCs (Aruffo, 1996; Nakamura and Ozawa, 1996).
Differentiation of FLG 29.1 cells into OC-like elements
involved up-regulation of  1,  5, and  v integrin chains
and de novo induction of  v 3,  3, and  3 integrins. Con-
sequently, adhesion of differentiated OC-like FLG 29.1 cells
to specific ECM molecules, such as FN, VN, LN-8, and LN-
10 were strongly up-regulated. Similarly, differentiation of
FLG 29.1 cells was accompanied by a striking induction of
CD44 expression, which conferred the capability to strongly
adhere also to HA substrates. In accordance with their inte-
grins profile, OC-like FLG 29.1 cells were able to migrate
toward membranes coated with FN, VN, and LNs, but com-
pletely failed to move toward HA substrates. Given the high
expression of CD44 molecules and the strong adhesion of
OC-like cells to HA, the lack of migration toward HA was
surprising. Moreover, soluble HA also strongly inhibited cell
migration of OC-like FLG 29.1 cells toward other ECM
substrates, such as FN, VN, and LN-10. This phenomenon
was clearly dependent on the engagement of CD44 because
the addition of specific anti-CD44 mAbs that blocked the
interaction with HA fully restored the motility.
CD44 is expressed in many migratory and metastatic
cells (Borland et al., 1998), and has been reported to pro-
vide motility and locomotion on HA-coated substrates in
vitro (Thomas et al., 1993; Okada et al., 1996; Trochon et
al., 1996; Ladeda et al., 1998; Okamoto et al., 1999; Oli-
ferenko et al., 2000; Kajita et al., 2001; Sohara et al., 2001).
The present findings describe a novel and apparently oppo-
site function for the CD44-HA pair, and raise the question
of the putative mechanism(s) by which the CD44-HA in-
Figure 7. Inhibition of MMP-9 and effects on cell migration. (A) Inhibition of migration toward FN by TIMP-1 and GM6001. 10  g/ml 
TIMP-1 and 4  g/ml GM6001 were added to the cultures, and the number of cells that migrated toward FN-coated Transwells at 24 h was 
evaluated. (B) Quantitation of MMP-9 mRNA in OC-like cells treated with MMP-9 antisense oligonucleotides. The cDNA prepared from OC-like 
cells treated with MMP-9–specific antisense oligonucleotides or control scrambled oligonucleotide (Contr.) was subjected to quantitative 
real-time PCR with primers specific for  2M and MMP-9. The left panel shows a graphic representation of one experiment where the x axis 
indicates the number of PCR cycles (Cycle) and the y axis (Rn) indicates the normalized reporter signal, i.e., the ratio between the fluorescence 
signals of the reporter dye and of the passive reference dye. The right panel shows the levels of MMP-9, expressed as MMP-9/ 2M ratios 
(am, attomoles) as obtained in two different experiments. (C) Inhibition of migration by MMP-9 antisense oligonucleotides. Representative 
fields of migrated cells at 24 h are shown on the left panel, and the quantitative data of migration, as obtained in two experiments, are shown 
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teraction may impair migration of OC-like FLG 29.1 cells
toward ECM substrates. HA was previously reported to in-
hibit macrophage migration in cross-linked fibrin gels also
containing FN (Lanir et al., 1988), although the underlying
mechanism had not been elucidated. In this paper, we in-
vestigated the possibility that the CD44-HA interaction
could prevent cell movement toward ECM ligands (a) by
directly masking the substrates and thus hampering the ac-
cess to their specific receptors, or (b) by modifying the af-
finity/avidity and/or the expression levels of specific inte-
grin receptors. Several observations argue against these
possibilities. First, soluble HA did not prevent cell adhesion
onto FN, VN, and LN-10. Second, growing OC-like FLG
29.1 cells in the presence of an excess of HA before per-
forming the CAFCA assay did not change the adhesion
strength of specific integrin receptors via an inside-out
mechanism. Consistently, the expression levels of specific
integrins were not modified by pretreatment with soluble
HA. In addition, the cytoplasmic domain of CD44, as ex-
pressed in FLG 29.1 cells, has the wild-type sequence (un-
published data), thus excluding the possibility that the lack
of migration toward HA might depend on a mutated serine
codon (Peck and Isacke, 1998) in this domain. Finally,
OC-like FLG 29.1 cells expressed almost exclusively the he-
mopoietic form and very low amounts of larger isoforms,
thus making it unlikely that the inhibitory effect exerted by
Figure 8. Relationships between CD44 engagement by HA and MMP-9 in OC-like FLG 
29.1 cells. (A) Dose–response inhibition of MMP-9 activity after CD44 engagement by HA. 
Cells were maintained for 24 h on tissue culture plastic, FN, or VN substrates. Quantitative 
evaluation of band intensities was performed by computer imaging. (B) Identification of MMP-9 
in cell supernatants. Aliquots of the cell supernatant from control HT1080 or OC-like cells 
maintained for 24 h in the absence or in the presence of 1.0 mg/ml of HA were precipitated 
with TCA, resolved on an 8% SDS-PAGE after reduction with 2- -mercaptoethanol, transferred 
to nitrocellulose, and probed with polyclonal anti–MMP-9 or  -actin antibodies. (C) Expression 
of MMP-9 in OC-like cells maintained for 24 h in the absence or presence of 1.0 mg/ml HA 
as evaluated by specific pAbs and confocal laser microscopy. In the bottom panel, cells 
were also treated with 10 ng/ml TNF- . Bar, 50  m. (D) Modulation of MMP-9 transcripts 
as evaluated by quantitative real-time PCR. The cDNA prepared from OC-like cells grown 
on FN or LN-10 substrates in the presence of HA or HA plus anti-CD44 blocking mAbs was 
subjected to quantitative real-time PCR with primers specific for  2M and MMP-9. The levels 
of MMP-9 are expressed as MMP-9/ 2M ratios of the abundance of MMP-9 transcripts to 
that of  2M transcripts (MMP-9/ 2M) calculated as 2n, where n is the Ct value of  2M minus 
the Ct value of MMP-9 as obtained in two experiments. (E) Immunoblotting of CD44. Pre-OC 
or OC-like cells incubated with HA (1 mg/ml) or with HA and TNF-  (10 ng/ml) for 24 h 
were collected, lysed, resolved on an 8% SDS-PAGE, transferred to nitrocellulose, and 
probed with pAbs against CD44. HA–CD44 binding down-regulates cell movement | Spessotto et al. 1141
HA on cell migration could be due to the expression of
atypical CD44 isoforms (Jiang et al., 2002).
Once established that the unexpected lack of migration on
HA and the HA-mediated inhibition of motility toward
ECM components were not due to intrinsic deficits of
CD44 nor to other effects on integrin expression and/or af-
finity/avidity, we hypothesized that HA might rather actively
participate in some specific regulatory aspects of OC-like cell
motility. Both cysteine proteinases and MMPs are essential
factors in the regulation of specific OC functions, including
migration to the bone surface and activation of bone resorp-
tion processes (Blavier and Delaisse, 1995; Vu et al., 1998;
Lee et al., 1999; Engsig et al., 2000). MMPs have been re-
ported to play a role in OC migration through collagen in
the periosteum (Sato et al., 1998) or within the developing
marrow cavity of long bones (Blavier and Delaisse, 1995;
Engsig et al., 2000). On the other hand, MMP inhibitors do
not seem to affect, or only marginally reduce, the resorptive
activity of isolated OCs seeded onto slices of devitalized bone
or dentine (Hill et al., 1994). Conversely, cysteine proteinase
inhibitors, although active on bone resorption, are unable to
impair OC migration through collagen (Blavier and De-
laisse, 1995; Sato et al., 1998; Lerner, 2000). Thus, cysteine
proteinases seem mainly involved in bone resorption pro-
cesses, whereas MMPs are the proteinases more likely re-
sponsible for OC motility (Everts et al., 1999; Lerner,
2000). In complete agreement with this notion, migration of
OC-like FLG 29.1 cells toward various ECM components,
including FN, VN, and LNs, was strongly dependent on
MMP-9, a proteinase expressed by normal OCs (Tezuka et
al., 1994; Okada et al., 1995), and resulted in the major if
not unique MMP detected in conditioned media and cell ly-
sates of fully differentiated OC-like FLG 29.1 cells. Al-
though MMP-9 was mainly released by OC-like cells in its
proenzyme form, active MMP-9 protein was detected in
OC-like cell lysates; these low amounts being significantly
increased upon induction by TNF-  (Zhang et al., 1998).
Interestingly, OC-like FLG 29.1 cells express high levels of
TNF-  mRNA, secrete discrete amounts of TNF- , and ex-
ogenous TNF-  has been shown to increase OC-like cell mi-
gration (unpublished data). Formal proof that MMP-9 is in-
volved in OC-like FLG 29.1 cell migration was obtained by
experiments with MMP inhibitors and MMP-9 antisense
oligonucleotides, which specifically knocked out MMP-9 ex-
pression and greatly reduced migration of OC-like cells to-
ward FN substrates without affecting CD44 expression. In
full accordance with this scenario, the expression of MMP-9
was strikingly down-regulated both at mRNA and protein
levels upon engagement of CD44 by soluble HA, suggesting
that the CD44-HA interaction interfered with OC-like FLG
29.1 cell migration by inhibiting the expression and/or func-
tion of the promigratory proteinase MMP-9.
That MMPs act by promoting cell migration has often
been associated with a direct cleavage of specific ECM com-
ponents. In this context, MMP-2 has been thought to be re-
sponsible for the migration of carcinoma cells toward ECM
substrates by degrading LN-5 (Giannelli et al., 1997). In
particular, because for cell migration to occur, ECM located
at the migratory direction has to be degraded, membrane-
bound MMPs seem to be optimally placed for pericellular
proteolysis associated with cell motility (Nagase and Woess-
ner, 1999; Seiki, 1999). Among membrane-bound MMPs,
MT-MMPs are directly tethered to the plasma membrane;
soluble MMPs also may act as membrane-bound MMPs by
using specific transmembrane receptor systems as docking
molecules. In this regard, CD44 has been demonstrated to
serve as a docking molecule to retain MMP-9 proteolytic ac-
tivity at the cell surface (Yu et al., 1997; Bourguignon et al.,
1998). Interestingly, no evidence for other gelatinolytic ac-
tivities in membrane extracts or for MT-MMPs mRNA ex-
pression were found in OC-like FLG 29.1 cells (unpub-
lished observation). Therefore, it is also conceivable that in
the FLG 29.1 cell system, migration via integrins toward
ECM is dependent on MMP-9 either associated to CD44
molecules at the cell surface (Bourguignon et al., 1998; Yu
and Stamenkovic, 1999) or released in tightly regulated
pulses of very small amounts of activated enzyme, resulting
in focalized matrix degradation (Espaza et al., 1999). The
notion that in OC-like FLG 29.1 cells CD44 and MMP-9
were both evenly distributed on cell membranes and cyto-
plasms, whereas the involved integrins are polarized (Martin
et al., 2002), does not argue against our interpretation of the
data.
Cleavage of CD44 molecules can result either in promo-
tion or impairment of cell migration (Espaza et al., 1999;
Okamoto et al., 1999; Ahrens et al., 2001; Kajita et al.,
2001). According to Kajita et al. (2001), cleavage of CD44
may be required to detach cells from HA and promote their
migration. However, in other cell systems, CD44 cleavage
can impair cell migration by disrupting the migration pro-
moting CD44–MMP-9 clusters (Espaza et al., 1999) or,
through the production of soluble fragments acting as decoy
receptors for HA, by reducing the number of HA molecules
directly bound to cells (Ahrens et al., 2001). In addition, as
shown for the first time by us in the OC-like FLG 29.1
model, impairment of cell migration may be independent
from CD44 cleavage but rather dependent on HA engage-
ment of CD44 followed by down-regulation of the promi-
gratory MMP-9 proteinase. Cleavage of CD44, as reported
by Kajita et al. (2001), may promote cell migration also by
rescuing cells from the inhibitory effect exerted by HA–
CD44 interactions on cell migration through MMP-9 down-
regulation.
The recent finding that human metastatic breast cancer
cells (Bourguignon et al., 2000) and murine epithelial cells
activate GTP-binding proteins (Oliferenko et al., 2000)
upon CD44 engagement through HA suggested that the sta-
tus of these proteins may be important for cell migration
(Bourguignon et al., 2000). Whether GTP-binding proteins
should similarly have a role in migrating OC-like cells re-
mains to be investigated. However, it should be pointed out
that because both integrins and CD44 are actively engaged
at the same time, the migration system analyzed by us with
OC-like cells is totally different from that studied in polar-
ized epithelial cells (Bourguignon et al., 2000; Oliferenko et
al., 2000). In fact, epithelial cells were investigated while mi-
grating either chemotactically toward soluble HA (Bour-
guignon et al., 2000) or after being locally stimulated by
microinjections of HA (Oliferenko et al., 2000), under ex-
perimental conditions in which only CD44 was engaged.1142 The Journal of Cell Biology | Volume 158, Number 6, 2002
OC-like cells migrating toward ECM molecules are actively
engaging cognate integrins as well as CD44, and the active
integrin-dependent migration is counteracted by the addi-
tion of soluble HA and its binding to CD44.
After the generation of preOCs from hemopoietic progen-
itors (Roodman, 1996), MMP-9 plays an important permis-
sive role in facilitating OC invasion into primitive long
bones of the marrow cavity (Blavier and Delaisse, 1995); a
process that is down-regulated by MMP inhibitors (Sato et
al., 1998). In the OC-like FLG 29.1 model, migration was
almost fully abrogated by TIMP-1 or GM6001, as well as by
specific antisense oligonucleotides, indicating that MMP-9
plays a fundamental promigratory function and that this ac-
tivity can be physiologically or pharmacologically modu-
lated. Our results suggest a mechanistic framework for the
observed association between engagement of CD44 by HA
and negative regulation of migration processes, and implies
that the regulation of pro- and antimigratory activity might
be a mechanism also playing a role in OC activity in vivo.
An attractive possibility is that other cells of the bone mi-
croenvironment, including osteoblasts and/or stromal or in-
flammatory cells (Roodman, 1996) may be stimulated to se-
crete HA by environmental cues or that stromal HA is
released from ECM. Soluble high molecular mass HA binds
then to CD44 and inhibits MMP-9 production. Such pro-
cess would eventually help avoiding excess ECM degrada-
tion and prevent migration of OCs to nearby sites to per-
form additional bone degradation. This hypothesis is in
accordance with the prevalent localization of CD44 on the
microvilli of the basolateral plasma membrane of OC cells
rather than in the area in direct contact with the bone sur-
face (Nakamura and Ozawa, 1996). The recent identifi-
cation of a peptide inhibitor of HA-mediated leukocyte
trafficking using phage display technology can provide a
pharmacological reagent that might also result useful in bal-
ancing excessive bone resorption by inhibiting the interac-
tions between HA and OC precursors, thus preventing their
migration toward bone sites (Mummert et al., 2000).
Materials and methods
Source and characteristics of antibodies and flow cytometry
Expression of various cell surface components was analyzed by single-color
direct or indirect immunofluorescence by using mAbs recognizing the
following:   1/CD29,   2/CD49b,   3/CD49c,   4/CD49d,   5/CD49e,   6/
CD49f,   2/CD18,   3/CD61 (Beckman Coulter/Immunotech S.A.),  9 1
complex (CHEMICON International, Inc.),  4, and  7. These latter mAbs, as
well as mAbs recognizing the standard CD44 isoform, were obtained
through the “Adhesion Structures” panel of the Fifth International Workshop
of Leukocyte Typing (Denning et al., 1995). As second step reagents, iso-
type-matched control mAbs and phycoerythrin-conjugated F(ab’)2 fragments
of goat anti–mouse Igs were purchased from Jackson ImmunoResearch Lab-
oratories. Viable, antibody-labeled cells were identified according to their
forward and side scatter, electronically gated, and assayed for surface fluo-
rescence on a FACScan
TM flow cytometer (Immunocytometry Systems, Bec-
ton Dickinson). In some instances, cells were labeled with FITC-conjugated
HA and similarly analyzed. Function-blocking mAbs recognizing specific
CD44 epitopes were from the Fifth International Workshop of Leukocyte
Typing (Denning et al., 1995), whereas anti- 1 (clone 4B4) was from
Coulter/Immunotech S.A., anti- 1 (clone FB12), anti- 3 (clone P1B5), anti-
 v 3 (clone LM 609), and anti- v 5 (clone P1F6) were obtained from
CHEMICON International, Inc., and anti- 6 (clone GoH3) was provided by
Dr. Arnoud Sonnenberg (Netherlands Cancer Institute, Amsterdam, Nether-
lands). Antibodies against MMP-9 were obtained from Santa Cruz Biotech-
nology, Inc. (M-17) or from CHEMICON International, Inc. (AB805).
ECM molecule
FN was purchased from Calbiochem-Novabiochem. VN was purified from
human plasma according to the procedure of Yatohgo et al. (1988). Rat tail
collagen type I was obtained from Collaborative Research Biochemicals.
Native LN-1 nidogen complex from EHS mouse tumor, LN-5, and LN-8
were obtained as described previously (Spessotto et al., 2001). LN-10 from
human placenta was purchased from CHEMICON International, Inc. Sev-
eral preparations of HA were purchased from Sigma-Aldrich (H1504,
H1751, H7630, and H1876) and Calbiochem-Novachem (385902).
Cells and culture conditions
The human preOC cell line FLG 29.1 was maintained in Iscove’s modi-
fied Dulbecco medium (IMDM; Seromed, Biochrom) supplemented with
L-glutamine (Seromed) and 10% FBS (Seromed) at 37 C and 5% CO2, and
induced into mature OC-like cells by treatment with 1.0   10
 7 M 12-
O-tetradecanoylphorbol-13-acetate (TPA; Sigma-Aldrich) for 72 h. Spe-
cific OC differentiation was determined by a number of morphological,
immunochemical, and molecular features (Gattei et al., 1992, 1996;
Fiorelli et al., 1994, 1995). In this paper, we refer to the uninduced FLG
29.1 cells as preOC and to the differentiated cells as OC-like cells.
Confocal laser scanning microscope
OC-like FLG 29.1, cultured in the presence or absence of 1 mg/ml HA,
were (a) stimulated with 10 ng/ml TNF-  for 24 h and centrifuged onto eth-
anol-cleaned slides; or (b) allowed to adhere onto FN-coated slides. In both
cases, slides were air dried and cells were fixed in PBS for 10 min at RT
with 3.7% formaldehyde and then permeabilized with 0.1% Triton X-100
for 2 min. Slides were extensively washed with 0.1% BSA/PBS and blocked
for 30 min with 2% BSA/PBS before application of antibodies. Incubation
with both primary (anti–MMP-9 M-17 and anti-CD44 F-10–44–2) antibod-
ies and secondary (matched FITC-conjugated anti-Ig; Jackson ImmunoRe-
search Laboratories) antibodies, diluted in 0.1% BSA/PBS (1:100) was per-
formed for 1 h at RT in a moist chamber. Actin staining was performed
using Texas red phalloidin (Molecular Probes, Inc.). Slides were then
mounted in MOWIOL
® 4-88 (Calbiochem-Novabiochem) containing 2.5%
1,4-diazabicyclo[2,2,2]octane (Sigma-Aldrich) as antifading agent. Immu-
nofluorescence-labeled cells were studied using a confocal laser scanning
microscope (Diaphot 200 [Nikon]; MRC-1024 [Bio-Rad Laboratories]).
RT-PCR, Southern blotting, and nucleotide sequencing
1 g total RNA, extracted from FLG 29.1 cells under different experimental
conditions by the guanidium-thiocyanate method, was reverse-transcribed
using avian myeloblastosis virus reverse transcriptase (Promega) for 1 h at
42 C in a 20- l mix containing 0.4  g hexadeoxyribonucleotides random
primers. All cDNA preparations were checked for first-strand synthesis as
described previously (Gattei et al., 1996). 2  l of the cDNA preparations
was amplified in a 50- l final volume containing 25 pmol of primers spe-
cific for  8 (sense, 5 -ACACCACCAACAACAGAAAGA-3 ; antisense, 5 -
AACTCCCCAGCAGCAACT-3 ) and  9 (sense, 5 -TTCCAAATACAGCC-
CTTCAGT-3 ; antisense, 5 -AAATATAAACCTTGCCGATGC-3 ) integrin
chains in a thermal cycler (PTC200; MJ Research, Inc.). Amplification con-
ditions were as follows: 35 cycles of 30 s at 94 C, 45 s at 62 C, 90 s at
72 C, and a final extension of 5 min at 72 C. For CD44 studies, we chose a
common sense primer, located on exon 5 (5 -GCAGCACTTCAGGAGGT-
TACA-3 ), used in conjunction with different antisense primers annealing
to exon 15 (5 -GGGTGGAATGTGTCTTGGTC-3 ), exon 10/v6 (5 -TCTG-
TTGCCAAACCACTGTTC-3 ), or exon 12/v8 (5 -GCTGCGTTGTCAT-
TGAAAGAG-3 ). For all primer pairs, the PCR amplification protocol was a
two-step procedure consisting of 3 min at 94 C followed by 35 cycles of 30 s
at 94 C and 75 s at 68 C. For Southern blotting, 10  l of amplified cDNA
was run on 1.5% agarose gel, blotted onto nylon membranes (Boehringer)
and hybridized with 2   10
6 cpm/ml of a common 
32P 5 -end-labeled oli-
goprobe recognizing specific sequences within the exon 5 of CD44 (5 -
ATGGGAGTCAAGAAGGTGGAGCAA-3 ). After washing to a final strin-
gency of 0.2  standard sodium cytrate-0.1  SDS, filters were exposed for
1.5 h to XAR-5 film (Kodak) at  80 C. For MMP-9 detection, cDNAs were
amplified with specific primers (sense, 5 -CACCATGAGCCTCTGGCAGC-
3 ; antisense, 5 -GCCCAGGGACCACAACTCGT-3 ) along with SYBR
®
Green PCR core reagents (Applied Biosystems) according to the manufac-
turer’s protocol. The incorporation of the SYBR
® Green dye into the PCR
products was monitored in real time with a sequence detection system (ABI
PRISM 7700; Applied Biosystems), resulting in the calculation of threshold
cycle (Ct value) that defines the PCR cycle number at which an exponential
growth of PCR product begins. The Ct values for  2-microglobulin ( 2M)
and MMP-9 were used to calculate the abundance of MMP-9 transcripts
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were as follows: sense, 5 -TCCAGCGTACTCCAAAGATTCA-3 ; antisense,
5 -AGATTAACCACAACCATGCCTTACT-3 .
Antisense oligonucleotide treatment
An antisense oligodeoxyribonucleoside methylphosphonate probe targeted
to the 5 -region of MMP-9 mRNA (from nucleotides  19 to  4: 5 -CUC-
AUGGUGAGGGCAGAGGUGUCU-3 ) and a control scrambled oligonu-
cleotide (5 -CUACGGGUAGGUGCGGAAUGGGUC-3 ) were synthesized.
PreOC cells were induced with TPA for 4 h, washed, and appropriate
amounts (2–10  M) of oligonucleotides were added for 24 h in the presence
of TPA. At the end of the incubation, an aliquot of the cells was solubilized,
total RNA was extracted, and the expression of MMP-9 was evaluated by
real-time PCR. Other cells were allowed to migrate toward FN-coated wells
(see Fluorescence-assisted transmigration invasion and motility assay
[FATIMA]) for 24 h and the fraction of migrated cells was then evaluated.
Zymography and Western blotting
PreOC and OC-like FLG29.1 cells were washed, resuspended (10
6 cells/
ml) in IMDM, and incubated with 10 ng/ml TNF-  for 24 h at 37 C. The
supernatants were collected, centrifuged at 15,000 rpm for 20 min at 4 C,
and the cells were lysed in 1 ml Tris buffer containing 1% Triton X-100.
Supernatants and cell lysates (150  l/well) were loaded onto SDS–acryl-
amide-gelatin gels (8% polyacrylamide, 0.1% gelatin). The gels were then
washed twice for 30 min with 50 mM Tris-HCl, pH 7.4, containing 2.5%
Triton X-100, incubated overnight at 37 C in 50 mM Tris-HCl, pH 7.4,
containing 150 mM NaCl and 10 mM CaCl2, stained for 30 min with 30%
methanol/10% acetic acid containing 0.5% Coomassie brilliant blue
R-250, destained, and finally photographed.
Supernatants, precipitated with TCA, were subjected to electrophoresis
on an 8% SDS-PAGE under reducing conditions and transferred to a nitro-
cellulose membrane. Membranes were incubated with rabbit anti–MMP-9
antibodies (AB805), and finally with peroxidase-labeled goat anti–rabbit an-
tibodies (Zymed Laboratories) followed by enhanced chemiluminescence
(ECL Plus; Amersham Biosciences). To visualize CD44, cell lysates obtained
from preOC and OC-like cells exposed to HA and TNF- , were subjected to
8% SDS-PAGE and Western blotting with anti-CD44 pAbs.
CAFCA
The quantitative cell adhesion assay used in this study has been described
extensively (Spessotto et al., 2000, 2001). In brief, polyvinyl chloride
6-well plates, CAFCA strips (Whatman Inc.), were coated with ECM mole-
cules. Cells were labeled with the vital fluorochrome calcein AM (Molecu-
lar Probes, Inc.) for 15 min at 37 C, and then aliquoted into the bottom
CAFCA miniplates at a density of 20–50   10
4 cells/ml. Cell adhesion to
substrates was assayed in PBS containing 0.5% polyvinyl pyrrolidone (PVP
360; Sigma Chemical Co.), 1 mmol/liter MgCl2, 1 mmol/liter CaCl2, and
2% India ink as a fluorescence quencher. In some instances, cells were
preincubated with function-blocking anti-integrin mAbs (1–10  g/ml) for
20 min at 37 C, and then plated onto the substrate. CAFCA miniplates
were centrifuged at 142 g for 5 min at 37 C to synchronize the contact of
the cells with the substrate, incubated for 20 min at 37 C, and mounted to-
gether with a similar CAFCA miniplate to create communicating chambers
for subsequent reverse centrifugation (45 g). In some experiments, different
detachment forces were applied to measure the strength of adhesion (from
45 g up to 400 g). The relative number of cells bound to the substrate and
cells that fail to bind to the substrate were estimated by top/bottom fluores-
cence detection in a computer-interfaced microplate fluorometer (SPEC-
TRAFluor Plus; Tecan), and fluorescence values were then elaborated.
Fluorescence-assisted transmigration invasion and motility
assay (FATIMA)
Migration experiments involving haptotactic movement of the cells through
a porous membrane were performed according to the FATIMA assay (Spes-
sotto et al., 2000). The procedure is based on the use of Transwell-like in-
serts, carrying a fluorescence-shielding porous PET membrane (polycarbon-
ate-like material; 8- m pores) (HTS FluoroBlok
TM inserts; Becton Dickinson)
or Transwells (Corning Costar Corporation) in cases where there was an in-
terest in examining the morphology of the migrated cells or counting the
number of cells per field under the microscope. The underside of the insert
membrane was coated with the various purified ECM molecules in bicar-
bonate buffer at 4 C overnight and blocked with 1% BSA for 1 h at RT.
Cells were fluorescently tagged with a lipophilic dye (DiI; Molecular
Probes, Inc.) at a final 5- g/ml concentration for 10–15 min at 37 C, resus-
pended in RPMI with 0.1% BSA, and aliquoted into the upper side of each
insert unit (10
5 cells/insert), with and without blocking or unrelated control
mAbs. In some cases, TIMP-1 (R & D Systems Europe Ltd.) and the MMP in-
hibitor GM6001 (CHEMICON International, Inc.) were added to the upper
chamber. Conditioned medium from the giant cell tumor–derived stromal
cell line C433 or NIH-3T3 cells was in some cases added to the lower
chamber to generate chemotactic effects. The time-dependent migratory
behavior of the cells was monitored by the SPECTRAFluor Plus microplate
fluorometer from the top (nonmigrated cells) and bottom (migrated cells)
side of the porous membrane. In some cases, migrated cells were counted
under inverted microscopy (magnification of 20). Results are expressed as
cells per field (minimum of 5–10 microscopy fields counted).
This work was supported in part by grants from the Associazione Italiana per
la Ricerca sul Cancro (V. Gattei), the FSN-Ricerca Finalizzata 1999–2000 (V.
Gattei) and 2000–2001 (V. Gattei and A. Colombatti) of the Ministero della
Sanità, and by research grants from the University of Parma (R. Perris).
Submitted: 26 February 2002
Revised: 16 July 2002
Accepted: 5 August 2002
References
Ahrens, T., J.P. Sleeman, C.M. Schempp, N. Howells, M. Hofmann, H. Ponta, P.
Herrlich, and J.C. Simon. 2001. Soluble CD44 inhibits melanoma tumor
growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene.
20:3399–3408.
Arai, F., T. Miyamoto, O. Ohneda, T. Inada, T. Sudo, K. Brasel, T. Miyata, D.M.
Anderson, and T. Suda. 1999. Commitment and differentiation of osteo-
clast precursor cells by the sequential expression of c-Fms and receptor acti-
vator of nuclear factor  B (RANK) receptors. J. Exp. Med. 190:1741–1754.
Aruffo, A. 1996. CD44: one ligand, two functions. J. Clin. Invest. 98:2191–2192.
Bartolazzi, A., A. Nocks, A. Aruffo, F. Spring, and I. Stamenkovic. 1996. Glycosy-
lation of CD44 is implicated in CD44-mediated cell adhesion to hyaluro-
nan. J. Cell Biol. 132:1199–1208.
Blavier, L., and J.M. Delaisse. 1995. Matrix metalloproteinases are obligatory for
the migration of preosteoclasts to the developing marrow cavity of primitive
long bones. J. Cell Sci. 108:3649–3659.
Bord, S., A. Horner, C.A. Beeton, R.M. Hembry, and J.E. Compston. 1999. Tis-
sue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal
and pathological human bone. Bone. 24:229–235.
Borland, G., J.A. Ross, and K. Guy. 1998. Forms and functions of CD44. Immu-
nology. 93:139–148.
Bourguignon, L.Y., Z. Gunja-Smith, N. Iida, H.B. Zhu, L.J. Young, W.J. Muller,
and R.D. Cardiff. 1998. CD44v(3,8-10) is involved in cytoskeleton-medi-
ated tumor cell migration and matrix metalloproteinase (MMP-9) associa-
tion in metastatic breast cancer cells. J. Cell. Physiol. 176:206–215.
Bourguignon, L.Y., H. Zhu, L. Shao, and Y.W. Chen. 2000. CD44 interaction
with Tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast
tumor cell migration. J. Biol. Chem. 275:1829–1838.
Denning, S.M., M.J. Telen, L.P. Hale, H.X. Liao, and B.F. Haynes. 1995. CD44
and CD44R cluster report. In Leucocyte Typing. V.S.F. Schlossman, L.
Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S.
Shaw, R. Silverstein, T. Springer, T.F. Tedder, and R.F. Todd, editors. Ox-
ford University Press, Inc., Oxford. 1713–1719.
Duong, L.T., P. Lakkakorpi, I. Nakamura, and G.A. Rodan. 2000. Integrins and
signaling in osteoclast function. Matrix Biol. 19:97–105.
Engsig, M.T., Q.J. Chen, T.H. Vu, A.C. Pedersen, B. Therkidsen, L.R. Lund, K.
Henriksen, T. Lenhard, N.T. Foged, Z. Werb, and J.M Delaisse. 2000. Ma-
trix metalloproteinase 9 and vascular endothelial growth factor are essential for
osteoclast recruitment into developing long bones. J. Cell Biol. 151:879–889.
Espaza, J., C. Vilardell, J. Calco, M. Juan, J. Vives, A. Urbano-Marquez, J. Yague,
and M.C. Cid. 1999. Fibronectin upregulates gelatinase B (MMP-9) and in-
duces coordinated expression of gelatinase A (MMP-2) and its activator
MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process re-
pressed through RAS/MAP kinase signaling pathways. Blood. 94:2754–2765.
Everts, V., W. Korper, D.C. Jansen, J. Steinfort, I. Lammerse, S. Heera, A.J. Do-
cherty, and W. Beertsen. 1999. Functional heterogeneity of osteoclasts: ma-
trix metalloproteinases participate in osteoclastic resorption of calvarial bone
but not in resorption of long bone. FASEB J. 13:1219–1230.
Fiorelli, G., R.T. Ballock, L.M. Wakefield, M.B. Sporn, F. Gori, L. Masi, U. Fre-
diani, A. Tanini, P.A. Bernabei, and M.L. Brandi. 1994. Role for autocrine
TGF-  1 in regulating differentiation of a human leukemic cell line toward
osteoclast-like cells. J. Cell. Physiol. 160:482–490.
Fiorelli, G., F. Gori, M. Petilli, A. Tanini, S. Benvenuti, M. Serio, P. Bernabei, and1144 The Journal of Cell Biology | Volume 158, Number 6, 2002
M.L. Brandi. 1995. Functional estrogen receptors in a human preosteoclas-
tic cell line. Proc. Natl. Acad. Sci. USA. 92:2672–2676.
Gattei, V., P.A. Bernabei, A. Pinto, R. Bezzini, A. Ringressi, L. Formigli, A. Ta-
nini, V. Attadia, and M.L. Brandi. 1992. Phorbol ester induced osteoclast-
like differentiation of a novel human leukemic cell line (FLG 29.1). J. Cell
Biol. 116:437–447.
Gattei, V., D. Aldinucci, J.M. Quinn, M. Degan, M. Cozzi, V. Perin, A. De Iuliis,
S. Juzbasic, S. Improta, N.A. Athanasou, et al. 1996. Human osteoclasts and
preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact
with osteoblast and stromal cells via membrane-bound stem cell factor. Cell
Growth Differ. 7:753–763.
Giannelli, G., J. Falk-Marzillier, O. Schiraldi, W.G. Stetler-Stevenson, and V.
Quaranta. 1997. Induction of cell migration by matrix metalloprotease-2
cleavage of laminin-5. Science. 277:225–228.
Hill, P.A., G. Murphy, A.J. Docherty, R.M. Hembry, T.A. Millican, J.J. Reynolds,
and M.C. Meikle. 1994. The effects of selective inhibitors of matrix metallo-
proteinases (MMPs) on bone resorption and the identification of MMPs
and TIMP-1 in isolated osteoclasts. J. Cell Sci. 107:3055–3064.
Holly, S.P., M.K. Larson, and L.V. Parise. 2000. Multiple roles of integrins in cell
motility. Exp. Cell Res. 261:69–74.
Ilangumaran, S., B. Borisch, and D.C. Hoessli. 1999. Signal transduction via CD44:
role of plasma membrane microdomains. Leuk. Lymphoma. 35:455–469.
Inaoka, T., G. Bilbe, O. Ishibashi, K. Tezuka, M. Kumegawa, and T. Kokubo. 1995.
Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase
predominantly expressed in bone. Biochem. Biophys. Res. Commun. 206:89–96.
Jiang, H., R.S. Peterson, W. Wang, E. Bartnick, C.B. Knudson, and W. Knudson.
2002. A requirement for the CD44 cytoplasmic domain for hyaluronan
binding, pericellular matrix assembly, and receptor-mediated endocytosis in
COS-7 cells. J. Biol. Chem. 277:10531–10538.
Kajita, M., Y. Itoh, T. Chiba, H. Mori, A. Okada, H. Kinoh, and M. Seiki. 2001.
Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell
migration. J. Cell Biol. 153:893–904.
Kania, J.R., T. Kehat-Stadler, and S.R. Kupfer. 1997. CD44 antibodies inhibit os-
teoclast formation. J. Bone Miner. Res. 12:1155–1164.
Lacey, D.L., E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott,
A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cy-
tokine that regulates osteoclast differentiation and activation. Cell. 93:165–176.
Ladeda, V., J.A. Aguirre Ghiso, and E. Bal de Kier Joffe. 1998. Function and ex-
pression of CD44 during spreading, migration, and invasion of murine car-
cinoma cells. Exp. Cell Res. 242:515–527.
Lanir, N., P.S. Ciano, L. van de Water, J. McDonagh, A.M. Dvorak, and H.F.
Dvorak. 1988. Macrophage migration in fibrin gel matrices. II. Effects of
clotting factor XIII, fibronectin, and glycosaminoglycan content on cell mi-
gration. J. Immunol. 140:2340–2349.
Lee, E.R., G. Murphy, M. El-Alfy, M.A. Davoli, L. Lamplugh, A.J. Docherty, and
C.P. Leblond. 1999. Active gelatinase B is identified by histozymography in the
cartilage resorption sites of developing long bones. Dev. Dyn. 215:190–205.
Lee, J.Y., and A.P. Spicer. 2000. Hyaluronan: a multifunctional, megaDalton,
stealth molecule. Curr. Opin. Cell Biol. 12:581–586.
Leppert, D., E. Waubant, R. Galardy, N.W. Bunnett, and S.L. Hauser. 1995. T
cell gelatinases mediate basement membrane transmigration in vitro. J. Im-
munol. 154:4379–4389.
Lerner, U.H. 2000. Osteoclast formation and resorption. Matrix Biol. 19:107–120.
Lesley, J., and R. Hyman. 1998. CD44 structure and function. Front. Biosci.
3:D616–D630.
Mangeat, P., C. Roy, and M. Martin. 1999. ERM proteins in cell adhesion and
membrane dynamics. Trends Cell Biol. 9:187–192.
Martin, K.H., J.K. Slack, S.A. Boerner, C.C. Martin, and J.T. Parson. 2002. Inte-
grin connections map: to infinity and beyond. Science. 296:1652–1653.
Mummert, M.E., M. Mohamadzadeh, D.I. Mummert, N. Mizumoto, and A.
Takashima. 2000. Development of a peptide inhibitor of hyaluronan-medi-
ated leukocyte trafficking. J. Exp. Med. 192:769–779.
Nagase, H., and J.F. Woessner, Jr. 1999. Matrix metalloproteinases. J. Biol. Chem.
274:21491–21494.
Nakamura, H., and H. Ozawa. 1996. Immunolocalization of CD44 and the ERM
family in bone cells of mouse tibiae. J. Bone Miner. Res. 11:1715–1722.
Naor, D., R.V. Sionov, and D. Ish-Shalom. 1997. CD44: structure, function, and
association with the malignant process. Adv. Cancer Res. 71:241–319.
Noonan, K.J., J.W. Stevens, R. Tammi, M. Tammi, J.A. Hernandez, and R.J. Mi-
dura. 1996. Spatial distribution of CD44 and hyaluronan in the proximal
tibia of the growing rat. J. Orthop. Res. 14:573–581.
Okada, H., J. Yoshida, M. Sokabe, T. Wakabayashi, and M. Hagiwara. 1996. Sup-
pression of CD44 expression decreases migration and invasion of human
glioma cells. Int. J. Cancer. 66:255–260.
Okada, Y., K. Naka, K. Kawamura, T. Matsumoto, I. Nakanishi, N. Fujimoto, H.
Sato, and M. Seiki. 1995. Localization of matrix metalloproteinase 9 (92-
kilodalton gelatinase/type IV collagenase   gelatinase B) in osteoclasts: im-
plications for bone resorption. Lab. Invest. 72:311–322.
Okamoto, I., Y. Kawano, H. Tsuiki, J. Sasaki, M. Nakao, M. Matsumoto, M.
Suga, M. Ando, M. Nakajima, and H. Saya. 1999. CD44 cleavage induced
by a membrane-associated metalloprotease plays a critical role in tumor cell
migration. Oncogene. 18:1435–1446.
Oliferenko, S., I. Kaverina, J.V. Small, and L.A. Huber. 2000. Hyaluronic acid
(HA) binding to CD44 activates Rac1 and induces lamellipodia outgrowth.
J. Cell Biol. 148:1159–1164.
Peck, D., and C.M. Isacke. 1998. Hyaluronan-dependent cell migration can be
blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine
at position 325. J. Cell Sci. 111:1595–1601.
Rochman, M., J. Moll, P. Herrlich, S.B. Wallach, S. Nedvetzki, R.V. Sionov, I.
Golan, D. Ish-Shalom, and D. Naor. 2000. The CD44 receptor of lym-
phoma cells: structure-function relationships and mechanism of activation.
Cell Adhes. Commun. 7:331–347.
Roodman, G.D. 1996. Advances in bone biology: the osteoclast. Endocr. Rev. 17:
308–332.
Sato, T., M. del Carmen Ovejero, P. Hou, A.M. Heegaard, M. Kumegawa, N.T.
Foged, and J.M. Delaisse. 1997. Identification of the membrane-type matrix
metalloproteinase MT1-MMP in osteoclasts. J. Cell Sci. 110:589–596.
Sato, T., N.T. Foged, and J.M. Delaisse. 1998. The migration of purified osteo-
clasts through collagen is inhibited by matrix metalloproteinase inhibitors. J.
Bone Miner. Res. 13:59–66.
Seiki, M. 1999. Membrane-type matrix metalloproteinases. APMIS. 107:137–143.
Sohara, Y., N. Ishiguro, K. Machida, H. Kurata, A.A. Thant, T. Senga, S. Mat-
suda, K. Kimata, H. Iwata, and M. Hamaguchi. 2001. Hyaluronan activates
cell motility of v-Src-transformed cells via ras-mitogen-activated protein ki-
nase and phosphoinositide 3-kinase-Akt in a tumor-specific manner. Mol.
Biol. Cell. 12:1859–1868.
Spessotto, P., E. Giacomello, and R. Perris. 2000. Fluorescence assays to study cell
adhesion and migration in vitro. Methods Mol. Biol. 139:321–343.
Spessotto, P., Z. Yin, G. Magro, R. Deutzmann, A. Chiu, A. Colombatti, and R.
Perris. 2001. Laminin isoforms 8 and 10 are primary components of the
subendothelial basement membrane promoting interaction with neoplastic
lymphocytes. Cancer Res. 61:339–347.
Teitelbaum, S.L. 2000. Bone resorption by osteoclasts. Science. 289:1504–1508.
Tezuka, K., K. Nemoto, Y. Tezuka, T. Sato, Y. Ikeda, M. Kobori, H. Kawashima,
H. Eguchi, Y. Hakeda, and M. Kumegawa. 1994. Identification of matrix
metalloproteinase 9 in rabbit osteoclasts. J. Biol. Chem. 269:15006–15009.
Thomas, L., T. Etoh, I. Stamenkovic, M.C. Mihm, Jr., and H.R. Byers. 1993. Mi-
gration of human melanoma cells on hyaluronate is related to CD44 expres-
sion. J. Invest. Dermatol. 100:115–120.
Trochon, V., C. Mabilat, P. Bertrand, Y. Legrand, F. Smadja-Joffe, C. Soria, B.
Delpech, and H. Lu. 1996. Evidence of involvement of CD44 in endothelial cell
proliferation, migration and angiogenesis in vitro. Int. J. Cancer. 66:664–668.
Vu, T.H., J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, D. Hanahan, S.D.
Shapiro, R.M. Senior, and Z. Werb. 1998. MMP-9/gelatinase B is a key reg-
ulator of growth plate angiogenesis and apoptosis of hypertrophic chondro-
cytes. Cell. 93:411–422.
Yatohgo, T., M. Izumi, H. Kashiwagi, and M. Hayashi. 1988. Novel purification
of vitronectin from human plasma by heparin affinity chromatography. Cell
Struct. Funct. 13:281–292.
Yu, Q., B.P. Toole, and I. Stamenkovic. 1997. Induction of apoptosis of metastatic
mammary carcinoma cells in vivo by disruption of tumor cell surface CD44
function. J. Exp. Med. 186:1985–1996.
Yu, Q., and I. Stamenkovic. 1999. Localization of matrix metalloproteinase 9 to
the cell surface provides a mechanism for CD44-mediated tumor invasion.
Genes Dev. 13:35–48.
Zhang, Y., K. McCluskey, K. Fujii, and L.M. Wahl. 1998. Differential regulation
of monocyte matrix metalloproteinase and TIMP-1 production by TNF- ,
granulocyte-macrophage CSF, and IL-1-  through prostaglandin-dependent
and –independent mechanisms. J. Immunol. 161:3071–3076.
Zhao, W., M.H. Byrne, B.F. Boyce, and S.M. Krane. 1999. Bone resorption in-
duced by parathyroid hormone is strikingly diminished in collagenase-resis-
tant mutant mice. J. Clin. Invest. 103:517–524.